Neil S. Belloff - Nov 8, 2021 Form 4 Insider Report for ACORDA THERAPEUTICS INC (ACOR)

Role
General Counsel
Signature
/s/ Neil S. Belloff
Stock symbol
ACOR
Transactions as of
Nov 8, 2021
Transactions value $
$0
Form type
4
Date filed
11/9/2021, 06:03 PM
Previous filing
Jul 30, 2021
Next filing
Apr 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACOR Employee Stock Option (right to buy) Award $0 +85K $0.00 85K Nov 8, 2021 Common Stock 85K $3.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options issued under the issuer's 2016 Inducement Plan. Twenty-five percent of the shares subject to the options vest on November 8, 2022. The balance of the shares vest in equal quarterly installments over the three years thereafter.